Your search history is turned on.
Date: May 1, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
2024-05-01 Duke Health NR.final Duke University Health Center One of Americas Top Heart-care Institutions and Innovators Purchases Ventripoints AI Heart-scan Technology Toronto, Ontario (May 1, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce that Duke University Health Center has...
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Management Discussion & Analysis VENTRIPOINT DIAGNOSTICS LTD. MANAGEMENTS DISCUSSION AND ANALYSIS FOR THE YEAR ENDED DECEMBER 31, 2023 VENTRIPOINT DIAGNOSTICS LTD. Managements Discussion & Analysis Year Ended December 31, 2023 Dated April 29, 2024 P a g e | 2 Introduction...
Date: April 29, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, JEON, Jimmy, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable d...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Jimmy Jeon, Chief Financial Officer of Ventripoint Diagnostics Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are ...
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Hugh MacNaught, President & Chief Executive Officer of Ventripoint Diagnostics Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and inform...
Ventripoint Diagnostics Ltd. - Q4 2023 FS (Final 4-29-2024).pdf VENTRIPOINT DIAGNOSTICS LTD. CONSOLIDATED FINANCIAL STATEMENTS YEARS ENDED DECEMBER 31, 2023 AND 2022 (EXPRESSED IN CANADIAN DOLLARS) Independent Auditor's Report To the Shareholders of Ventripoint Diagnostics Ltd.: Opinion We have audited the consolidated financial statements of Ventripoint ...
Date: April 11, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - 2024-04-11 Announcing Debenture Unit Private Placement.final NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Ventripoint Announces Non-Brokered Convertible Debenture Private Placement Toronto, Ontario, April 11, 2024 Ventripoint Diagnostics Ltd. (Ventripoint or the Corporati...
Date: March 28, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
2024-03-28 VPT Corporate Update.Final Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call Toronto, Ontario The Newswire March 28, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to provide a corporate update on the Companys current status and the outlook for 2024. The...
Date: February 20, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
2024-02-20 Ventripoint-Germany-Conference.Final Ventripoint Successfully Showcases A.I.- Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences For Immediate Release Hamburg, Germany February 20, 2024 Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is delighted to report its par...